Brazil requires prescription for Ozempic, similar drugs now

istoe.com.br (Portuguese)

Starting today, June 23, 2025, a medical prescription is required to purchase GLP-1 receptor agonists like Ozempic and Mounjaro, according to a new regulation by Anvisa. This aims to curb irresponsible use. The new rule, effective immediately, seeks to combat the widespread, often inappropriate use of these medications, sometimes called "weight loss pens." Medical professionals believe this will help prevent misuse and ensure proper patient monitoring. The decision follows concerns about the drugs' accessibility and their promotion for weight loss without proper medical guidance. The requirement mirrors that of antibiotics, with pharmacies retaining prescriptions for tracking.


With a significance score of 3.2, this news ranks in the top 11% of today's 31668 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Brazil requires prescription for Ozempic, similar drugs now | News Minimalist